CN Patent

CN105524067A — 4-取代吡咯并[2,3-d]嘧啶化合物及其用途

Assigned to Nanjing Carefree Pharmaceutical Co Ltd · Expires 2016-04-27 · 10y expired

What this patent protects

本发明涉及一种4-取代吡咯并[2,3-d]嘧啶化合物，及其在制备治疗类风湿、免疫系统疾病、肿瘤等JAK相关靶点疾病的药物中的用途。本发明所述的4-取代吡咯并[2,3-d]嘧啶化合物如化学结构式I所示。活性结果表明，部分式（I）所示化合物对Janus系列激酶的具有较强抑制作用。

USPTO Abstract

本发明涉及一种4-取代吡咯并[2,3-d]嘧啶化合物，及其在制备治疗类风湿、免疫系统疾病、肿瘤等JAK相关靶点疾病的药物中的用途。本发明所述的4-取代吡咯并[2,3-d]嘧啶化合物如化学结构式I所示。活性结果表明，部分式（I）所示化合物对Janus系列激酶的具有较强抑制作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN105524067A
Jurisdiction
CN
Classification
—
Expires
2016-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Carefree Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.